Literature DB >> 106682

Familial hyperphosphatasemia: diagnosis in early infancy and response to human thyrocalcitonin therapy.

V Dunn, V R Condon, M L Rallison.   

Abstract

Familial hyperphosphatasemia is an uncommon hereditary disorder of membranous bone with concurrent overproduction and overdestruction of bone and bone collagen by osteocytes. This process does not allow normal maturation into compact lamellar bone. Two cases of severely affected children are presented which demonstrate that the condition can be diagnosed in early infancy by abnormalities in the long bones. At this stage the skull may appear normal and the characteristic thickening of the calvarium appears later. The disease is treatable with human thyrocalcitonin; these and previously reported cases have responded favorably.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106682     DOI: 10.2214/ajr.132.4.541

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Familial hyperphosphatasemia.

Authors:  P Gupta; A Arora; J S Luthra; A Kumar; D P Rathour
Journal:  Indian J Pediatr       Date:  2000-11       Impact factor: 1.967

2.  Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers.

Authors:  C Wüster; W Schurr; S Scharla; F Raue; H W Minne; R Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Post-partum hypercalcemia in hereditary hyperphosphatasia (juvenile Paget's disease).

Authors:  N Chosich; F Long; R Wong; D J Topliss; J R Stockigt
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

Review 4.  Craniotubular bone disorders.

Authors:  R J Gorlin
Journal:  Pediatr Radiol       Date:  1994

Review 5.  Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene.

Authors:  Giacomina Brunetti; Flaviana Marzano; Silvia Colucci; Annamaria Ventura; Luciano Cavallo; Maria Grano; Maria Felicia Faienza
Journal:  Endocrine       Date:  2012-05-26       Impact factor: 3.633

6.  Camurati-Engelmann disease: imaging, clinical features and differential diagnosis.

Authors:  Aldona Bartuseviciene; Arturas Samuilis; Jovitas Skucas
Journal:  Skeletal Radiol       Date:  2009-02-12       Impact factor: 2.199

Review 7.  Pharmacology and therapeutic use of calcitonin.

Authors:  J C Stevenson; I M Evans
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.